Plerixafor, also known by its brand name Mozobil, is a medication used in combination with other drugs to stimulate the production of stem cells in the bone marrow. This drug is commonly used in patients undergoing stem cell transplantation for conditions such as multiple myeloma and non-Hodgkin’s lymphoma.

Plerixafor works by blocking a protein called CXCR4, which helps stem cells stay in the bone marrow. By inhibiting this protein, plerixafor allows stem cells to be released into the bloodstream where they can be collected for transplantation.

It is important to follow your healthcare provider’s instructions when taking plerixafor, as the dosage and administration schedule can vary depending on your specific condition and treatment plan. Common side effects of plerixafor may include nausea, diarrhea, fatigue, and injection site reactions. It is important to report any severe or persistent side effects to your healthcare provider.

Before starting plerixafor, be sure to inform your healthcare provider about any other medications or supplements you are taking, as they may interact with plerixafor. Additionally, let your healthcare provider know if you have any allergies or medical conditions that may affect your ability to take plerixafor safely.

Overall, plerixafor is an important medication in the treatment of certain cancers and other conditions that require stem cell transplantation. By working with your healthcare provider and following their guidance, you can ensure that you are receiving the best possible care while taking plerixafor.